An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study

INTRODUCTION: A selective combination of C-reactive protein and albumin (termed the modified Glasgow Prognostic Score, mGPS) has been shown to have prognostic value, independent of tumour stage, in lung, gastrointestinal and renal cancers. It is also of interest that liver function tests such as bil...

Descripción completa

Detalles Bibliográficos
Autores principales: Proctor, M J, Morrison, D S, Talwar, D, Balmer, S M, O'Reilly, D S J, Foulis, A K, Horgan, P G, McMillan, D C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049591/
https://www.ncbi.nlm.nih.gov/pubmed/21266974
http://dx.doi.org/10.1038/sj.bjc.6606087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049591/
https://www.ncbi.nlm.nih.gov/pubmed/21266974
http://dx.doi.org/10.1038/sj.bjc.6606087

Ejemplares similares